MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy.
Chen YangTingting ShaoHuihui ZhangNinghan ZhangXiaoying ShiXuejiao LiuYao YaoLinyan XuShengyun ZhuJiang CaoHai ChengZhiling YanZhenyu LiMingshan NiuKailin XuPublished in: Journal of translational medicine (2018)
The expression of miR-425 may be useful in identifying patients in need of strategies to select the optimal therapy between chemotherapy and allo-HSCT treatment regimens. Patients with low miR-425 expression may consider early allo-HSCT.
Keyphrases
- long non coding rna
- cell proliferation
- poor prognosis
- long noncoding rna
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- stem cell transplantation
- ejection fraction
- locally advanced
- genome wide
- squamous cell carcinoma
- stem cells
- peritoneal dialysis
- low dose
- dna methylation
- rectal cancer
- smoking cessation
- cell therapy